C1GALT1 and colorectal cancer: C1GALT1 over-expression—associated with tumor growth, metastasis, and poor prognosis—has been observed in various cancers—viz., ovarian cancer [20], head and neck cancer [13], hepatocellular carcinoma [21], breast cancer [10], colorectal cancer [22], and gastric cancer [12].